Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuko Tsuchiya

Showing results (41-50 of 69) with videos related to

Pageof 7
Sort By:
Thoracic Cancer|April 13, 2022
Clinical efficacy of dacomitinib in rechallenge setting for patients with epidermal growth factor receptor mutant non-small cell lung cancer: A multicenter retrospective analysis (TOPGAN2020-02)Hisashi Tanaka, Hiroaki Sakamoto, Takahiro Akita, et al.
Translational Lung Cancer Research|December 15, 2022
Association of thyroid transcription factor-1 (TTF-1) expression with efficacy of PD-1/PD-L1 inhibitors plus pemetrexed and platinum chemotherapy in advanced non-squamous non-small cell lung cancerRitsu Ibusuki, Yasuto Yoneshima, Mikiko Hashisako, et al.
Cancer Immunology, Immunotherapy : CII|August 28, 2023
Second-line immunosuppressant administration for steroid-refractory immune-related adverse events in patients with lung cancerShinsuke Ogusu, Yuhei Harutani, Takehiro Tozuka, et al.
The FEBS Journal|July 5, 2006
Silencing the constitutive active transcription factor CREB by the LKB1-SIK signaling cascadeYoshiko Katoh, Hiroshi Takemori, Xing-Zi Lin, et al.
BMC Infectious Diseases|August 22, 2021
Risk factors for disease progression in Japanese patients with COVID-19 with no or mild symptoms on admissionToshifumi Ninomiya, Kohei Otsubo, Teppei Hoshino, et al.
BMC Cancer|May 6, 2022
A propensity score-matched analysis of the impact of statin therapy on the outcomes of patients with non-small-cell lung cancer receiving anti-PD-1 monotherapy: a multicenter retrospective studyKazuki Takada, Mototsugu Shimokawa, Shinkichi Takamori, et al.
International Journal of Cancer|March 15, 2021
Clinical impact of probiotics on the efficacy of anti-PD-1 monotherapy in patients with nonsmall cell lung cancer: A multicenter retrospective survival analysis study with inverse probability of treatment weightingKazuki Takada, Mototsugu Shimokawa, Shinkichi Takamori, et al.
Molecular Biology of the Cell|September 2, 2016
Conformational plasticity of JRAB/MICAL-L2 provides "law and order" in collective cell migrationAyuko Sakane, Shin Yoshizawa, Masaomi Nishimura, et al.
Protein Science : a Publication of the Protein Society|August 18, 2017
New tools and functions in data-out activities at Protein Data Bank Japan (PDBj)Akira R Kinjo, Gert-Jan Bekker, Hiroshi Wako, et al.
European Journal of Cancer (Oxford, England : 1990)|July 3, 2022
Antibiotic-dependent effect of probiotics in patients with non-small cell lung cancer treated with PD-1 checkpoint blockadeKazuki Takada, Sebastiano Buti, Melissa Bersanelli, et al.
Pageof 7

Showing results (41-50 of 69) with videos related to

Sort By:
Pageof 7
Thoracic Cancer|April 13, 2022
Clinical efficacy of dacomitinib in rechallenge setting for patients with epidermal growth factor receptor mutant non-small cell lung cancer: A multicenter retrospective analysis (TOPGAN2020-02)Hisashi Tanaka, Hiroaki Sakamoto, Takahiro Akita, et al.
Translational Lung Cancer Research|December 15, 2022
Association of thyroid transcription factor-1 (TTF-1) expression with efficacy of PD-1/PD-L1 inhibitors plus pemetrexed and platinum chemotherapy in advanced non-squamous non-small cell lung cancerRitsu Ibusuki, Yasuto Yoneshima, Mikiko Hashisako, et al.
Cancer Immunology, Immunotherapy : CII|August 28, 2023
Second-line immunosuppressant administration for steroid-refractory immune-related adverse events in patients with lung cancerShinsuke Ogusu, Yuhei Harutani, Takehiro Tozuka, et al.
The FEBS Journal|July 5, 2006
Silencing the constitutive active transcription factor CREB by the LKB1-SIK signaling cascadeYoshiko Katoh, Hiroshi Takemori, Xing-Zi Lin, et al.
BMC Infectious Diseases|August 22, 2021
Risk factors for disease progression in Japanese patients with COVID-19 with no or mild symptoms on admissionToshifumi Ninomiya, Kohei Otsubo, Teppei Hoshino, et al.
BMC Cancer|May 6, 2022
A propensity score-matched analysis of the impact of statin therapy on the outcomes of patients with non-small-cell lung cancer receiving anti-PD-1 monotherapy: a multicenter retrospective studyKazuki Takada, Mototsugu Shimokawa, Shinkichi Takamori, et al.
International Journal of Cancer|March 15, 2021
Clinical impact of probiotics on the efficacy of anti-PD-1 monotherapy in patients with nonsmall cell lung cancer: A multicenter retrospective survival analysis study with inverse probability of treatment weightingKazuki Takada, Mototsugu Shimokawa, Shinkichi Takamori, et al.
Molecular Biology of the Cell|September 2, 2016
Conformational plasticity of JRAB/MICAL-L2 provides "law and order" in collective cell migrationAyuko Sakane, Shin Yoshizawa, Masaomi Nishimura, et al.
Protein Science : a Publication of the Protein Society|August 18, 2017
New tools and functions in data-out activities at Protein Data Bank Japan (PDBj)Akira R Kinjo, Gert-Jan Bekker, Hiroshi Wako, et al.
European Journal of Cancer (Oxford, England : 1990)|July 3, 2022
Antibiotic-dependent effect of probiotics in patients with non-small cell lung cancer treated with PD-1 checkpoint blockadeKazuki Takada, Sebastiano Buti, Melissa Bersanelli, et al.
Pageof 7